Navigation Links
Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
Date:6/19/2008

SYDNEY, Australia, June 19 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that the company and the U.S. Food and Drug Administration (FDA) have reached agreement on the phase 3 registration trial of Bronchitol for bronchiectasis via the Special Protocol Assessment process.

The SPA process allows for FDA evaluation of a clinical trial protocol intended to form the primary basis of an efficacy claim in support of a New Drug Application, and provides an agreement that the study design, including trial size, clinical endpoints and/or data analyses are acceptable to the FDA.

Pharmaxis previously agreed on the trial design with the European regulatory agency (EMEA). This trial will therefore form the basis of a marketing application in both the U.S. and Europe.

The phase 3 trial has been designed in collaboration with internationally renowned experts in the field of bronchiectasis and will be a randomized, placebo controlled, double-blind investigation of Bronchitol twice daily in approximately 350 adults with bronchiectasis. Participants will be treated for 52 weeks and the primary endpoints are reduction in frequency of exacerbations and improvement in quality of life. Secondary endpoints include time to first exacerbation and duration of exacerbation. Additional secondary endpoints are antibiotic use, sputum volume, exercise tolerance and lung function measurements. The trial includes health economic analysis and will be conducted in centers across Europe and the U.S.

This trial is the second Phase III study to be undertaken for Bronchitol in bronchiectasis and follows the completion of a successful shorter trial reported last year.

Pharmaxis CEO, Alan Robertson, said the company was pleased to have concluded its discussions with the FDA and the EMEA.

''We believe this phase 3 trial design will allow us to thoroughly demonstrate the clinical benefits of Bronchitol in a patient populat
'/>"/>

SOURCE Pharmaxis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmaxis Establishes Named Patient Program for Bronchitol
2. Pharmaxis Long-Term Safety Study of Bronchitol Completes
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
5. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
6. Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
7. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
8. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
9. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
10. Specialized Genasense(R) Clinical Trials Featured at AACR Meeting
11. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014  Pressure BioSciences, Inc. (OTCQB: ... has received and approved all parts required to ... has begun to manufacture the new PCT-based instrument ... be ready for shipment by mid-October and that ... at a rate of about one per week ...
(Date:9/19/2014)... Tenn. , Sept. 19, 2014  Over 200 ... the Future to Benefit the Radiation Oncology Institute (ROI), ... held at Golden Gate Park in San Francisco.  ... Dan Moore , CEO of Radiation Business Solutions, ... we have raised over $70,000 for the ROI this ...
(Date:9/19/2014)... , Sept. 19, 2014  PCI is ... International (Biotec).  Biotec is a leading provider of ... headquartered in Bridgend, Wales ...  The addition significantly expands PCI,s presence in the ... products by adding packaging, storage and distribution capacity, ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
... Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced today ... Pharma A/S and Santaris Pharma A/S Corp. in the ... California.  Isis, infringement suit against Santaris is based upon ... services to several pharmaceutical companies.  As alleged in the ...
... London-based technology-driven marketing solutions company U.S. Branding Group, ... they will be participating at DigiPharm Europe, Sept. ... marketing conference for senior pharmaceutical executives. The conference ... enhance online communication, customer relationship, strengthen brand awareness ...
Cached Medicine Technology:Isis Pharmaceuticals Files Patent Infringement Suit Against Santaris Pharma 2Isis Pharmaceuticals Files Patent Infringement Suit Against Santaris Pharma 3U.S. Branding Group Ltd. to Sponsor DigiPharm Europe 2011, Showcase PharmaDrive™ USB Insert™ Paper Webkey 2
(Date:9/20/2014)... Las Vegas, NV (PRWEB) September 21, 2014 ... created by Dr. Kenneth Pullman that is helping thousands ... reverse their diabetes symptoms without shots, pills, or prescriptions ... investigative review. , “There are currently tens of ... with both Type 1 and Type 2 diabetes, and ...
(Date:9/20/2014)... Islands of Loreto, Baja, Mexico (PRWEB) September 20, 2014 ... of Loreto today announced the resort did not experience ... fully operational, with all amenities and activities available. , ... September 14, 2014, bringing intense wind, rain and powerful ... Baja Peninsula, Villa del Palmar Islands of Loreto experienced ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 As ... grow in federal court, Bernstein Liebhard LLP notes ... Administration (FDA) have voted overwhelmingly to recommend that ... men be subjected to further study in order ... report published on September 18th by Bloomberg.com, the ...
(Date:9/20/2014)... The festival season is coming soon. The ... released luxurious cocktail dresses . A lot of sophisticated ... to launch a new promotion for its high quality clothes. ... discounted price, from 20 to 71 percent off. , ... choices. They are provided in many fashionable colors. Mary, the ...
(Date:9/20/2014)... Recently, Best Cheap Hosting USA ... its new website. The new site provides the ... products for customers. Here, people can find a ... decision. Also, it has recommended some excellent web ... of the great web hosting suppliers, InMotion ( ...
Breaking Medicine News(10 mins):Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2
... Treatment after oxygen deprivation accounts for better motor skills ... -- Babies who are deprived of oxygen at birth ... has shown that cooling infants can help prevent problems. ... actually reduces the number of brain lesions in the ...
... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), ... http://www.cordblood-america.com ) focused on bringing the ... policy for families nationwide and internationally, today addressed shareholder ... its recently refiled S1 with the SEC, in an ...
... ... almost anyone to sustain life in the first critical minutes of cardiac arrest. ... vital organs alive until professional rescuers arrive. AED (Automated External Defibrillator) is an ... to a normal heartbeat. AEDs are very accurate and easy to use. With ...
... ... in infrared light therapy products, launches the Freedom 300, a new product for the treatment ... World Diabetes Day, 100% of the gross proceeds from sales from the Freedom 300 on ... , ...
... ETEX Corporation, an advanced biomaterials company, announced today ... California. Alphatec Spine will market and sell ETEX,s ... basis in the United States. , (Logo: ... Initial sales and marketing efforts will be focused ...
... The following was released today by Randall Terry: , On ... outside in the hall at Nancy Pelosi,s office, #235 Cannon office ... bill - all 2,000 pages (4,000) - and proceeded to rip ... , Approximately 150 supporters were in the hall, chanting: "Kill the ...
Cached Medicine News:Health News:Cord Blood America Updates Advantages of Las Vegas Laboratory in Analyst Interview; Explains Recent S1 Filing 2Health News:A New Era of E-Learning in the Comfort and Convenience of Your Home or Office Without the Classroom Environment 2Health News:Anodyne Therapy, LLC Develops Device For Treatment of Foot and Leg Pain And Pledges Donation In Honor Of World Diabetes Day 2Health News:Anodyne Therapy, LLC Develops Device For Treatment of Foot and Leg Pain And Pledges Donation In Honor Of World Diabetes Day 3Health News:ETEX Corporation Announces Distribution Agreement with Alphatec Spine 2Health News:ETEX Corporation Announces Distribution Agreement with Alphatec Spine 3
The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
... ACCU-Beam® line of Surgical Microscope Accessories includes ... fiber optic cables, and fiberoptic retrofits. TTI ... pat. no. 5,264,928) is the only adaptor ... cameras on the same adaptor body. It ...
Inquire...
... have been optimized to complete the range ... interact in perfect synchronization with the ALLEGRETTO ... and patient parameters are transferred from the ... systems via diskette, mini CD or memory ...
Medicine Products: